document_id
stringlengths 32
32
| age
int64 17
105
| gender
stringclasses 2
values | test_name
stringlengths 1
100
⌀ | display_ranges
stringlengths 1
662
⌀ | value
stringlengths 1
255
| unit
stringlengths 1
15
⌀ | specimen
stringclasses 12
values | loinc
stringclasses 581
values |
---|---|---|---|---|---|---|---|---|
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | % TRANSFERRIN SATURATION | null | 25.4100 | % | blood | 2502-3 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | IRON | null | 98.6000 | ug/dl | null | 2498-4 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | TOTAL IRON BINDING CAPACITY (TIBC) | null | 388.0000 | ug/dl | blood | 2500-7 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | ALANINE TRANSAMINASE (SGPT) | < 34.0 | 29.4600 | U/I | blood | 1742-6 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | ALBUMIN SERUM | 3.2 - 4.8 | 4.4400 | gm/dl | blood | 1751-7 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | ALKALINE PHOSPHATASE | 45.0 - 129.0 | 63.8300 | U/L | blood | 6768-6 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | ASPARTATE AMINOTRANSFERASE (SGOT ) | < 31.0 | 26.9200 | U/I | blood | 1920-8 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | BILIRUBIN (INDIRECT) | 0.0 - 0.9 | 0.4800 | mg/dl | blood | 1971-1 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | BILIRUBIN -DIRECT | < 0.3 | 0.2100 | mg/dl | blood | 1968-7 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | BILIRUBIN TOTAL | 0.3 - 1.2 | 0.6900 | mg/dl | blood | 1975-2 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | GAMMA GLUTAMYL TRANSFERASE (GGT) | < 38.0 | 75.8900 | U/I | blood | 2324-2 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | PROTEIN TOTAL | 5.7 - 8.2 | 7.3800 | gm/dl | blood | 2885-2 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | SERUM ALB/GLOBULIN RATIO | 0.9 - 2.0 | 1.5100 | Ratio | blood | 1759-0 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | SERUM GLOBULIN | 2.5 - 3.4 | 2.9400 | gm/dL | blood | 2336-6 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | HDL CHOLESTEROL DIRECT | 35.0 - 80.0 | 73.0000 | mg/dl | blood | 2085-9 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | LDL / HDL RATIO | 1.5 - 3.5 | 0.9000 | Ratio | blood | 11054-4 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | LDL CHOLESTEROL DIRECT | 85.0 - 130.0 | 64.0000 | mg/dl | blood | 2089-1 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | NON-HDL CHOLESTEROL | < 160.0 | 101.2500 | mg/dl | blood | 43396-1 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | TC/ HDL CHOLESTEROL RATIO | 3.0 - 5.0 | 2.4000 | Ratio | blood | 9830-1 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | TOTAL CHOLESTEROL | 125.0 - 200.0 | 174.0000 | mg/dl | blood | 2093-3 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | TRIGLYCERIDES | 25.0 - 200.0 | 137.0000 | mg/dl | blood | 2571-8 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | VLDL CHOLESTEROL | 5.0 - 40.0 | 27.3900 | mg/dl | blood | 2091-7 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | THYROID STIMULATING HORMONE (TSH) | 0.3 - 5.5 | 0.4700 | uIU/ml | blood | 3016-3 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | TOTAL THYROXINE (T4) | 4.5 - 12.0 | 6.0000 | ug/dl | blood | 3026-2 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | TOTAL TRIIODOTHYRONINE (T3) | 60.0 - 200.0 | 97.0000 | ng/dl | blood | 3053-6 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | BLOOD UREA NITROGEN (BUN) | 7.0 - 25.0 | 13.4100 | mg/dl | blood | 3094-0 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | BUN / SR.CREATININE RATIO | 9:1-23:1 | 26.2900 | Ratio | blood | 3097-3 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | CALCIUM | 8.8 - 10.6 | 9.3500 | mg/dl | blood | 17861-6 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | CREATININE SERUM | 0.5 - 0.8 | 0.5100 | mg/dl | blood | 2160-0 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | URIC ACID | 3.2 - 6.1 | 5.8400 | mg/dl | blood | 3084-1 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | EST. GLOMERULAR FILTRATION RATE (eGFR) | null | 96.0000 | mL/min/1.73 m2 | blood | 69405-9 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | AVERAGE BLOOD GLUCOSE (ABG) | null | 143.0000 | mg/dl | blood | 27353-2 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | HbA1c (HPLC NGSP Certified) | null | 6.6000 | % | blood | 4548-4 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | BASOPHILS | < 2.0 | 0.2000 | % | blood | 30180-4 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | BASOPHILS ABSOLUTE COUNT | 0.02 - 0.1 | 0.0200 | X 10 ³ / uL | blood | 26444-0 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | EOSINOPHILS | 0.0 - 6.0 | 4.5000 | % | blood | 26450-7 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | EOSINOPHILS ABSOLUTE COUNT | 0.02 - 0.5 | 0.3400 | X 103 / pL | blood | 26449-9 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | HEMATOCRIT(PCV) | 36.0 - 46.0 | 42.4000 | % | blood | 20570-8 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | HEMOGLOBIN | 12.0 - 15.0 | 12.5000 | g/dL | blood | 718-7 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | IMMATURE GRANULOCYTE PERCENTAGE(IG%) | 0.0 - 0.4 | 0.1000 | % | blood | 38518-7 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | IMMATURE GRANULOCYTES(IG) | 0.0 - 0.3 | 0.0100 | X 10³ / uL | blood | 51584-1 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | LYMPHOCYTE PERCENTAGE | 20.0 - 40.0 | 27.8000 | % | blood | 26478-8 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | LYMPHOCYTES ABSOLUTE COUNT | 1.0 - 3.0 | 2.1200 | X 10 ³ / uL | blood | 26474-7 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | MEAN CORP.HEMO.CONC(MCHC) | 31.5 - 34.5 | 29.5000 | g/dL | blood | 28540-3 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | MEAN CORPUSCULAR HEMOGLOBIN(MCH) | 27.0 - 32.0 | 29.1000 | pq | blood | 28539-5 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | MEAN CORPUSCULAR VOLUME(MCV) | 83.0 - 101.0 | 98.6000 | fL | blood | 30428-7 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | MEAN PLATELET VOLUME(MPV) | 6.5 - 12.0 | 14.6000 | fL | blood | 28542-9 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | MONOCYTES | 0.0 - 10.0 | 5.1000 | % | blood | 26485-3 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | MONOCYTES ABSOLUTE COUNT | 0.2 - 1.0 | 0.3900 | X 10 superscrip | blood | 26484-6 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | NEUTROPHILS | 40.0 - 80.0 | 62.3000 | % | blood | 53797-7 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | NEUTROPHILS ABSOLUTE COUNT | 2.0 - 7.0 | 475.0000 | X 103/uL | blood | 26499-4 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | NUCLEATED RED BLOOD CELLS | <0.01 | nil | X 103/UL | blood | null |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | NUCLEATED RED BLOOD CELLS % | <0.01 | nil | % | blood | 19048-8 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | PLATELET COUNT | 150.0 - 400.0 | 173.0000 | X 10 ³ / uL | blood | 26515-7 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | PLATELET TO LARGE CELL RATIO(PLCR) | 19.7 - 42.4 | 63.6000 | % | blood | 48386-7 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | PLATELETCRIT(PCT) | 0.19 - 0.39 | 0.2500 | % | blood | 51637-7 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | RED CELL DISTRIBUTION WIDTH SD(RDW-SD) | 39.0 - 46.0 | 54.5000 | fL | blood | 30384-2 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | TOTAL LEUCOCYTES COUNT | 4.0 - 10.0 | 7.6200 | X 10 ³ / uL | blood | 26464-8 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | TOTAL RBC | 3.9 - 4.8 | 4.3000 | X 10^6/uL | blood | 26453-1 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Absolute Eosinophil Count | 20.0 - 500.0 | 216.7500 | cells/micro L | blood | 26449-9 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Absolute Lymphocyte Count | 1000.0 - 3000.0 | 2384.2500 | cells/micro L | blood | 26474-7 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Absolute Neutrophil Count | 2000.0 - 7000.0 | 5644.1700 | cells/micro L | blood | 26499-4 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Basophils | < 2.0 | 0.6000 | % | blood | 30180-4 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Eosinophils | 1.0 - 6.0 | 2.5000 | % | blood | 26450-7 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Haemoglobin-HB | 13.0 - 17.0 | 14.1000 | g/dL | blood | 718-7 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Lymphocytes | 20.0 - 40.0 | 27.5000 | % | blood | 26478-8 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | MCH (Mean Corpuscular Haemoglobin) | 27.0 - 32.0 | 29.1000 | pg | blood | 28539-5 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | MCHC (Mean Corpuscular Haemoglobin | 31.5 - 34.5 | 33.0000 | g/dL | blood | 28540-3 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | MCV (Mean Corpuscular Volume) | 83.0 - 101.0 | 88.0000 | fL | blood | 30428-7 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Monocytes | 2.0 - 10.0 | 4.3000 | % | blood | 26485-3 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | N/L Ratio | 1.0 - 3.0 | 2.3700 | ratio | null | null |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Neutrophils | 40.0 - 80.0 | 65.1000 | % | blood | 53797-7 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | PCV (Haematocrit) | 40.0 - 50.0 | 42.7000 | % | blood | 20570-8 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Red Cell Distribution Width CV | 11.5 - 15.0 | 13.4000 | % | blood | 30385-9 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Red Cell Distribution Width SD | 39.0 - 46.0 | 43.5000 | fL | blood | 30384-2 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Total RBC Count | 4.5 - 5.5 | 4.8500 | Million/uL | blood | 26453-1 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Total WBC Count | 4000.0 - 10000.0 | 8670.0000 | cells/cumm | blood | 26464-8 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Absolute Basophil Count | 20.0 - 100.0 | 52.0200 | cells/micro L | blood | 26444-0 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Absolute Monocyte Count | 200.0 - 1000.0 | 372.8100 | cells/micro L | blood | 26484-6 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | ESR (Erythrocyte Sedimentation Rate) | 5.0 - 20.0 | 18.0000 | mm/hr | blood | 30341-2 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Estimated Average Glucose (eAG) | null | 108.2800 | mg/dl | blood | 27353-2 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Glycosylated Haemoglobin-HbA1c | impaired glucose tolerance: 5.7
6.4
diabetes: > 6.5
non diabetic level: < 5.70 | 5.4000 | % | blood | 4548-4 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | HDL Cholesterol-Direct | 40.0 - 60.0 | 46.0700 | mg/dL | blood | 2085-9 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Mean Platelet volume | 6.5 - 12.0 | 10.9000 | fL | blood | 28542-9 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Platelet Count | 150.0 - 450.0 | 318.0000 | Thousand/uL | blood | 26515-7 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Platelet distribution width-CV | null | 13.0000 | % | blood | 51631-0 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Platelet distribution width-SD | null | 9.5000 | fL | blood | 32207-3 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Platelet to large cell ratio (PLCR) | 19.7 - 42.4 | 31.8000 | % | blood | 48386-7 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Plateletcrit | 19.7 - 42.4 | 35.0000 | % | blood | 51637-7 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Total Cholesterol | borderline high: 200-239
high: > 239
desirable: < 200 | 237.8900 | mg/dL | blood | 2093-3 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Triglycerides | normal: < 150
high: 150-199
hypertriglyceridemic: 200-499
very high: > 500 | 125.5600 | mg/dL | blood | 2571-8 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | BUN-Blood Urea Nitrogen | 6.0 - 20.0 | 7.6900 | mg/dL | blood | 3094-0 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Bicarbonate | 23.0 - 29.0 | 25.0000 | mEq/L | blood | 1963-8 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Chloride | 98.0 - 107.0 | 102.0000 | mEq/L | blood | 2075-0 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Cholesterol / Hdl Ratio | 3.9 - 5.0 | 5.1600 | ratio | blood | 9830-1 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Creatinine | 0.62 - 1.1 | 0.9200 | mg/dL | blood | 2160-0 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | LDL / HDL Ratio | high risk: more than 6.0
borderline: 3.0-4.0
optimal: less than 3.0 | 3.6400 | ratio | blood | 11054-4 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | LDL Cholesterol-Direct | optimal: < 100
near optimal/above optimal: 100
129
borderline high: 130-159
high: 160-189
very high: > 190 | 167.5700 | mg/dL | blood | 2089-1 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Non Hdl Cholesterol | < 140.0 | 191.8200 | mg/dL | blood | 43396-1 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Potassium | 3.5 - 5.1 | 3.8000 | mEq/L | blood | 2823-3 |
Subsets and Splits